Top Markets
#1 Siren Siren +33.88%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.74%
#3 Wiki Cat Wiki Cat +18.78%
#4 Ribbita by Virtuals Ribbita by Virtuals +18.13%
#5 PulseChain PulseChain +16.92%
#6 Bitway Bitway +16.57%
#7 Velvet Velvet +16.09%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.45%
#9 Perle Perle +15.21%
#10 Cysic Cysic +14.98%
Coin of the day
Siren Siren
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
FunPep Company Limited FunPep Company Limited

FunPep Company Limited

4881
Pozycja w akcjach #30951
FunPep Company Limited specializes in the discovery and advancement of... FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-0379, a functional peptide designed to address skin ulcers. FunPep is advancing FPP003, an antibody-inducing peptide, which is undergoing Phase II clinical trials for psoriasis in Australia and for ankylosing spondylitis in Japan. Another antibody-inducing peptide, FPP004X, is also in development, targeting pollinosis. Additionally, the company is working on FPP006, a corona peptide vaccine, and FPP005, an antibody-inducing peptide for psoriasis. Established in 2013, FunPep Company Limited operates from its headquarters in Tokyo, Japan.
Cena akcji
$0.33274288
Kapitalizacja rynkowa
$14.92M
Zmiana (1 dzień)
2.00%
Zmiana (1 rok)
-57.59%
Kraj
JP
Handel FunPep Company Limited (4881)

Kategoria

Healthcare
Zyski dla FunPep Company Limited (4881)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych FunPep Company Limited, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy FunPep Company Limited od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE